Why this beaten down ASX 200 healthcare stock could rebound 66%

It has been a tough week for Neuren Pharmaceuticals Ltd (ASX: NEU) shares.

Since this time last week, the ASX 200 healthcare stock is down 20%.

Is this a buying opportunity? Let’s see what Bell Potter is saying about the pharmaceuticals company.

What is the broker saying about this ASX 200…